Candida tropicalis: Its prevalence, pathogenicity and increasing resistance to fluconazole

Journal of Medical Microbiology

Volumn 59, Issue 8, 2010, Pages 873-880

  Kothavade, Rajendra J ^a   Kura, M M ^b   Valand, Arvind G ^b   Panthaki, M H ^c  

^a EPCOR   (Canada)

^b SIR J J GROUP OF HOSPITALS   (India)

^c Sir Hurkisondas Nurrotumdas Hospital & Research Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; KETOCONAZOLE; MICONAZOLE; ANTIFUNGAL AGENT;

ANTIBIOTIC RESISTANCE; CANDIDA TROPICALIS; CANDIDIASIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HUMAN; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INFECTION SENSITIVITY; PATHOGENICITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; ANTIFUNGAL RESISTANCE; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ANTIFUNGAL AGENTS; CANDIDA TROPICALIS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HUMANS; PREVALENCE;

EID: 77955295116     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.013227-0     Document Type: Review

References (72)

1. Anil, S. & Samaranayake, L. P. (2003). Brief exposure to antimycotics reduces the extracellular phospholipase activity of Candida albicans and Candida tropicalis. Chemotherapy 49, 243-247. (Pubitemid 37188094)
2. Antonopoulou, S., Aoun, M., Alexopoulos, E. C., Baka, S., Logothetis, E., Kalambokas, T., Zannos, A., Papadias, K., Grigoriou, O. & other authors (2009). Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes. Antimicrob Agents Chemother 53, 2181-2184.
3. Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S. & Scalise, G. (2000). Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother 44, 1578-1584. (Pubitemid 30340798)
4. Barnett, J. A., Payne, R. W. & Yarrow, D. (1990). Yeasts: Characteristics and Identification, 2nd edn. Cambridge: Cambridge University Press.
5. Bodey, G. P. (1984). Candidiasis in cancer patients. Am J Med 77, 13-19.
6. Borg, M. & Rüchel, R. (1990). Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis. J Med Vet Mycol 28, 3-14. (Pubitemid 20308812)
7. Borg-von Zepelin, M., Beggah, S., Boggian, K., Sanglard, D. & Monod, M. (1998). The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol Microbiol 28, 543-554. (Pubitemid 28218399)
8. Brun, S., Bergès, T., Poupard, P., Vauzelle-Moreau, C., Renier, G., Chabasse, D. & Bouchara, J.-P. (2004). Mechanisms of azole resistance in petite mutants of Candida glabrata. Antimicrob Agents Chemother 48, 1788-1796. (Pubitemid 38544390)
9. Buesching, W. J., Kurek, K. & Roberts, G. D. (1979). Evaluation of the modified API 20C system for identification of clinically important yeasts. J Clin Microbiol 9, 565-569. (Pubitemid 9158409)
10. Cantorna, M. T. & Balish, E. (1990). Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect Immun 58, 1093-1100. (Pubitemid 20117045)
11. Capobianco, J. O., Lerner, C. G. & Goldman, R. C. (1992). Application of a fluorogenic substrate in the assay of proteolytic activity and in the discovery of a potent inhibitor of Candida albicans aspartic proteinase. Anal Biochem 204, 96-102.
12. Clark, R. A., Blakley, S. A., Rice, J. & Brandon, W. (1995). Predictors of HIV progression in women. J Acquir Immune Defic Syndr Hum Retrovirol 9, 43-50.
13. Davis, S. L., Vazquez, J. A. & McKinnon, P. S. (2007). Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients. Ann Pharmacother 41, 568-573. (Pubitemid 46625479)
14. Dixon, T. C., Steinbach, W. J., Benjamin, D. K., Jr, Williams, L. W. & Myers, L. A. (2004). Disseminated Candida tropicalis in a patient with chronic mucocutaneous candidiasis. South Med J 97, 788-790.
15. Ellis, M. (2002). Invasive fungal infections: evolving challenges for diagnosis and therapeutics. Mol Immunol 38, 947-957. (Pubitemid 34496954)
16. Fromtling, R. A., Abruzzo, G. K. & Giltinan, D. M. (1987). Candida tropicalis infection in normal, diabetic, and neutropenic mice. J Clin Microbiol 25, 1416-1420.
17. Fung, J. J. (2002). Fungal infections in liver transplantation. Transpl Infect Dis 4, 18-23.
18. Gokce, G., Cerikcioglu, N. & Yagci, A. (2007). Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia 164, 265-269. (Pubitemid 47622126)
19. González-Gravina, H., González-de Morán, E., Zambrano, O., Lozano-Chourio, M., Rodríguez-de Valero, S., Robertis, S. & Mesa, L. (2007). Oral Candidiasis in children and adolescents with cancer. Identification of Candida spp. Med Oral Patol Oral Cir Bucal 12, E419-E423.
20. Gronemeyer, P. S., Weissfeld, A. S. & Sonnenwirth, A. C. (1982). Purulent pericarditis complicating systemic infection with Candida tropicalis. Am J Clin Pathol 77, 471-475.
21. Gruber, A., Lell, C. P., Spruth, M., Lass-Flörl, C., Speth, C., Stoiber, H., Hube, B., Coleman, D., Polonelli, L. & other authors (2003). HIV-1 and its transmembrane protein gp41 bind to different Candida species modulating adhesion. FEMS Immunol Med Microbiol 37, 77-83. (Pubitemid 36588930)
22. Hsueh, P. R., Lau, Y. J., Chuang, Y. C., Wan, J. H., Huang, W. K., Shyr, J. M., Yan, J. J., Yu, K. W., Wu, J. J. & other authors (2005). Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: Surveillance of Multicenter Antimicrobial Resistance in Taiwan program data from 2003. Antimicrob Agents Chemother 49, 512-517.
23. Husain, S., Tollemar, J., Dominguez, E. A., Baumgarten, K., Humar, A., Paterson, D. L., Wagener, M. M., Kusne, S. & Singh, N. (2003). Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 75, 2023-2029. (Pubitemid 36793286)
24. Imam, N., Carpenter, C. C. J., Mayer, K. H., Fisher, A., Stein, M. & Danforth, S. B. (1990). Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 89, 142-146. (Pubitemid 20254437)
25. Jacobs, P. H. & Nall, L. (editors) (1990). Antifungal Drug Therapy: a Complete Guide for the Practitioner, pp. 32-45. New York: Marcel Dekker.
26. Jorge, A. O. C., Totti, M. A. G., de Almeida, O. P. & Scully, C. (1993). Oral candidiasis established in the sialoadenectomised rat. J Oral Pathol Med 22, 54-56.
27. Joseph-Horne, T. & Hollomon, D. W. (1997). Molecular mechanisms of azole resistance in fungi. FEMS Microbiol Lett 149, 141-149. (Pubitemid 27163337)
28. Kao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A. & other authors (1999). The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 29, 1164-1170.
29. Khazim, R. M., Debnath, U. K. & Fares, Y. (2006). Candida albicans osteomyelitis of the spine: progressive clinical and radiological features and surgical management in three cases. Eur Spine J 15, 1404-1410.
30. Kirkpatrick, C. H. (1989). Chronic mucocutaneous candidiasis. Eur J Clin Microbiol Infect Dis 8, 448-456.
31. Kirkpatrick, C. H., Rich, R. R. & Bennett, J. E. (1971). Chronic mucocutaneous candidiasis: model building in cellular immunity. Ann Intern Med 74, 955-978.
32. Kontoyiannis, D. P., Vaziri, I., Hanna, H. A., Boktour, M., Thornby, J., Hachem, R., Bodey, G. P. & Raad, I. I. (2001). Risk factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 33, 1676-1681. (Pubitemid 33044532)
33. Kothari, A. & Sagar, V. (2009). Epidemiology of Candida bloodstream infections in a tertiary care institute in India. Indian J Med Microbiol 27, 171-172.
34. Kothavade, R. J. & Panthaki, M. H. (1998). Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice. J Med Microbiol 47, 99-102.
35. Krasner, R. I. (2002). Concepts of microbial disease. In The Microbial Challenge: Human-Microbe Interactions, chapter 6, pp. 103-120. Washington, DC: American Society for Microbiology.
36. Krawczyk, B., Leibner-Ciszak, J., Mielech, A., Nowak, M. & Kur, J. (2009). PCR melting profile (PCR MP) - a new tool for differentiation of Candida albicans strains. BMC Infect Dis 9, 177.
37. Myerowitz, R. L., Pazin, G. J. & Allen, C. M. (1977). Disseminated candidiasis: changes in incidence, underlying diseases, and pathology. Am J Clin Pathol 68, 29-38.
38. Myoken, Y., Kyo, T., Fujihara, M., Sugata, T. & Mikami, Y. (2004). Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies. Haematologica 89, 378-380. (Pubitemid 38788434)
39. Ng, K. P., Madasamy, M., Saw, T. L., Baki, A., He, J. & Soo-Hoo, T. S. (1998). Candida biotypes isolated from clinical specimens in Malaysia. Mycopathologia 144, 135-140. (Pubitemid 29478197)
40. Nissapatorn, V., Lee, C., Fatt, Q. K. & Abdullah, K. A. (2003). AIDS-related opportunistic infections in Hospital Kuala Lumpur. Jpn J Infect Dis 56, 187-192. (Pubitemid 38208628)
41. Nucci, M. & Colombo, A. (2007). Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals. Diagn Microbiol Infect Dis 58, 77-82. (Pubitemid 46694266)
42. Odds, F. C. (1988). Chronic mucocutaneous candidiosis. In Candida and Candidosis, pp. 104-110. Baltimore, MD: University Park Press.
43. Okumura, Y., Inoue, N. & Nikai, T. (2007). Isolation and characterization of a novel acid proteinase, tropiase from Candida tropicalis IFO 0589. Nippon Ishinkin Gakkai Zasshi 48, 19-25. (Pubitemid 46280131)
44. Parthiban, C. J. K. B., Majeed, S. A. & Mahalingam, S. S. (2008). Candida tropicalis spondylodiskitis in a patient with carcinoma of sigmoid colon: a case report. Cases J 1, 66.
45. Paya, C. V. (1993). Fungal infections in solid-organ transplantation. Clin Infect Dis 16, 677-688.
46. Perfect, J. R. (2004). Antifungal resistance: the clinical front. Oncology (Williston Park) 18 (Suppl. 13), S15-S22.
47. Pfaller, M. A., Boyken, L., Hollis, R. J., Kroeger, J., Messer, S. A., Tendolkar, S., Diekema, D. J. & ARTEMIS DISK Global Antifungal Surveillance Group (2009). Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program. Diagn Microbiol Infect Dis 65, 27-34.
48. Prasad, K. N., Agarwal, T., Dixit, A. K., Tiwari, D. P., Dhole, T. N. & Ayyagari, A. (1999). Role of yeast as nosocomial pathogens and their susceptibilities to fluconazole and amphotericin B. Indian J Med Res 110, 11-17.
49. Rhoads, J. L., Wright, D. C., Redfield, R. R. & Burke, D. S. (1987). Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 257, 3105-3107. (Pubitemid 17078924)
50. Roilides, E., Farmaki, E., Evdoridou, J., Francesconi, A., Kasai, M., Filioti, J., Tsivitanidou, M., Sofianou, D., Kremenopoulos, G. & Walsh, T. J. (2003). Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol 41, 735-741. (Pubitemid 36184189)
51. Rüchel, R. (1986). Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. Microbiol Sci 3, 316-319.
52. Rüchel, R., Böning, B. & Borg, M. (1986). Characterization of a secretory proteinase of Candida parapsilosis and evidence for the absence of the enzyme under conditions of infection in vitro. Infect Immun 53, 411-419. (Pubitemid 16073874)
53. Rüchel, R., Zimmermann, F., Böning-Stutzer, B. & Helmchen, U. (1991). Candidiasis visualized by proteinase-directed immunofluorescence. Virchows Arch A Pathol Anat Histopathol 419, 199-202.
54. Sandford, G. R., Merz, W. G., Wingard, J. R., Charache, P. & Saral, R. (1980). The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 142, 503-509.
55. Sanglard, D. & Odds, F. C. (2002). Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2, 73-85. (Pubitemid 36114141)
56. Schrank, J. H., Jr & Dooley, D. P. (1995). Purulent pericarditis caused by Candida species: case report and review. Clin Infect Dis 21, 182-187.
57. Shiraki, Y., Ishibashi, Y., Hiruma, M., Nishikawa, A. & Ikeda, S. (2008). Candida albicans abrogates the expression of interferon-gamma-inducible protein-10 in human keratinocytes. FEMS Immunol Med Microbiol 54, 122-128.
58. Sim, J. P., Kho, B. C., Liu, H. S., Yung, R. & Chan, J. C. (2005). Candida tropicalis arthritis of the knee in a patient with acute lymphoblastic leukaemia: successful treatment with caspofungin. Hong Kong Med J 11, 120-123. (Pubitemid 40545516)
59. Singh, A., Bairy, I. & Shivananda, P. G. (2003). Spectrum of opportunistic infections in AIDS cases. Indian J Med Sci 57, 16-21. (Pubitemid 39663088)
60. Stein, D. K. & Sugar, A. M. (1989). Fungal infections in the immunocompromised host. Diagn Microbiol Infect Dis 12, 221S-228S.
61. Stone, H. H., Kolb, L. D., Cume, C. A., Geheber, C. E. & Cuzzell, J. Z. (1974). Candida sepsis: pathogenesis and principles of treatment. Ann Surg 179, 697-711.
62. Tortorano, A. M., Rigoni, A. L., Biraghi, E., Prigitano, A., Viviani, M. A. & FIMUA-ECMM Candidemia Study Group (2003). The European Confederation of Medical Mycology (ECMM) survey of candidemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood. J Antimicrob Chemother 52, 679-682.
63. Vazquez, J. A. & Sobel, J. D. (1995). Fungal infections in diabetes. Infect Dis Clin North Am 9, 97-116.
64. Verma, A. K., Prasad, K. N., Singh, M., Dixit, A. K. & Ayyagari, A. (2003). Candidaemia in patients of a tertiary health care hospital from north India. Indian J Med Res 117, 122-128. (Pubitemid 37203477)
65. Vermitsky, J. P. & Edlind, T. D. (2004). Azole resistance in Candida glabrata: coordinate up-regulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob Agents Chemother 48, 3773-3781.
66. Walsh, T. J. & Merz, W. G. (1986). Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am J Clin Pathol 85, 498-502.
67. Weinberger, M., Sacks, T., Sulkes, J., Shapiro, M. & Polacheck, I. (1997). Increasing fungal isolation from clinical specimens: experience in a university hospital over a decade. J Hosp Infect 35, 185-195. (Pubitemid 27145969)
68. White, M. H. (1996). Is vulvovaginal candidiasis an AIDS-related illness. Clin Infect Dis 22, S124-S127.
69. Wingard, J. R., Merz, W. G. & Saral, R. (1979). Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med 91, 539-543.
70. Wingard, J. R., Dick, J.D., Merz, W. G., Sandford, G. R., Saral, R. & Burns, W. H. (1980). Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect Immun 29, 808-813. (Pubitemid 10040201)
71. Winston, D. J., Pakrasi, A. & Busuttil, R. W. (1999). Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 131, 729-737.
72. Yang, Y. L., Ho, Y. A., Cheng, H. H., Ho, M. & Lo, H. J. (2004). Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Infect Control Hosp Epidemiol 25, 60-64. (Pubitemid 38139848)